Immunopathology of multiple sclerosis

Dendrou, Calliope A., Fugger, Lars, Friese, Manuel A.·2015·Nature Reviews Immunology

Cited by (1,003)

Items 601–700 of 1,003

  1. HLA DR2b-binding peptides from human endogenous retrovirus envelope, Epstein-Barr virus and brain proteins in the context of molecular mimicry in multiple sclerosis
    Ranjan Ramasamy, Fiyaz Mohammed, Ute-C. Meier · 2019 · Immunology Letters
  2. One, No One, and One Hundred Thousand: T Regulatory Cells' Multiple Identities in Neuroimmunity
    Manolo Sambucci, Francesca Gargano, Gisella Guerrera, Luca Battistini, Giovanna Borsellino · 2019 · Frontiers in Immunology
  3. Neurocognitive impairment and social cognition in multiple sclerosis
    Triantafyllos K. Doskas, George D. Vavougios, Panagiota Karampetsou, Constantinos Kormas, Emmanouil Synadinakis, Konstantina Stavrogianni, Pinelopi Sionidou, Aspasia Serdari, Theofanis Vorvolakos, Ioannis Iliopoulos et al. · 2021 · International Journal of Neuroscience
  4. ILC3, a Central Innate Immune Component of the Gut-Brain Axis in Multiple Sclerosis
    Djordje M. Miljković, Bojan Jevtić, Ivana Stojanović, Mirjana Dimitrijević · 2021 · Frontiers in Immunology
  5. Tetramerization of STAT5 promotes autoimmune-mediated neuroinflammation
    Kelly Lynn Monaghan, Drake Aesoph, Amanda Gatesman Ammer, Wen Zheng, Shokofeh Rahimpour, Breanne Y. Farris, Camille A. Spinner, Peng Li, Jian‐Xin Lin, Zu‐Xi Yu et al. · 2021 · Proceedings of the National Academy of Sciences
  6. Specificity of Adaptive Immune Responses in Central Nervous System Health, Aging and Diseases
    Chiara Rickenbach, Christoph Gericke · 2022 · Frontiers in Neuroscience
  7. Autophagy modulation in multiple sclerosis and experimental autoimmune encephalomyelitis
    Donghui Shen, Kang Liu, Hongyan Wang, Haifeng Wang · 2022 · Clinical & Experimental Immunology
  8. Role of Demyelination in the Persistence of Neurological and Mental Impairments after COVID-19
    Marina Y. Khodanovich, Daria A. Kamaeva, Anna V. Naumova · 2022 · International Journal of Molecular Sciences
  9. B cell targeted therapies in inflammatory autoimmune disease of the central nervous system
    Moritz J. Furman, Sven Guenther Meuth, Philipp Albrecht, Michael Dietrich, Heike Blum, Jan Mareš, Ron Milo, Hans‐Peter Hartung · 2023 · Frontiers in Immunology
  10. The developing role of extracellular vesicles in autoimmune diseases: special attention to mesenchymal stem cell-derived extracellular vesicles
    Geovanny Genaro Reiván Ortiz, Neelam Hazoor Zaidi, Ravinder Singh Saini, Andrés Alexis Ramírez‐Coronel, Tahani Alsandook, Methaq Hadi Lafta, José Luis Arias‐Gonzáles, Ali H. Amin, Renato Racelis Maaliw III · 2023 · International Immunopharmacology
  11. Haematopoietic stem cell transplantation for treatment of relapsing-remitting multiple sclerosis in Sweden: an observational cohort study
    Thomas Silfverberg, Christina Zjukovskaja, Per T Ljungman, Adjmal Nahimi, Erik Ahlstrand, Arta Dreimane, Sigrun Einarsdottir, Jan Fagius, Ellen Iacobaeus, Hans Hägglund et al. · 2023 · Journal of Neurology Neurosurgery & Psychiatry
  12. Anti-B-Cell Therapies in Autoimmune Neurological Diseases: Rationale and Efficacy Trials
    Harry Alexopoulos, Angie Biba, Marinos C. Dalakas · 2015 · Neurotherapeutics
  13. Protamine neutralizes chondroitin sulfate proteoglycan-mediated inhibition of oligodendrocyte differentiation
    Kazuya Kuboyama, Naomi Tanga, Ryoko Suzuki, Akihiro Fujikawa, Masaharu Noda · 2017 · PLoS ONE
  14. Various strategies to improve efficacy of stem cell transplantation in multiple sclerosis: Focus on mesenchymal stem cells and neuroprotection
    Forouzan Yousefi, Fahimeh Lavi Arab, Kolsoum Saeidi, Houshang Amiri, Mahmoud Mahmoudi · 2018 · Journal of Neuroimmunology
  15. Natural products: Potential therapeutic agents in multiple sclerosis
    Shuangwen Yu, Mei Liu, Kaili Hu · 2018 · International Immunopharmacology
  16. The neuro-glial coagulonome: the thrombin receptor and coagulation pathways as major players in neurological diseases
    Efrat Shavit Stein, Shany Guly Gofrit · 2019 · Neural Regeneration Research
  17. Intranasal Methylprednisolone Effectively Reduces Neuroinflammation in Mice With Experimental Autoimmune Encephalitis
    Dunia Rassy, Brandon Bárcena, Ivan Nicolás Pérez‐Osorio, Alejandro Espinosa, Alberto N. Peón, Luis Ignacio Terrazas, Gabriela Meneses, Hugo O. Besedovsky, Gladis Fragoso, Edda Sciutto · 2019 · Journal of Neuropathology & Experimental Neurology
  18. Interferon-gamma ameliorates experimental autoimmune encephalomyelitis by inducing homeostatic adaptation of microglia
    Juan Enrique Tichauer, Gabriel Arellano, Eric Acuña, Luis F. González, Nirmal Raman Kannaiyan, Paola Murgas, Concepción Panadero-Medianero, Jorge Ibañez-Vega, Paula Isabel Burgos, Eileah Loda et al. · 2023 · Frontiers in Immunology
  19. The contribution of tumor necrosis factor to multiple sclerosis: a possible role in progression independent of relapse?
    Valentina Mazziotti, Francesco Crescenzo, Ermanna Turano, Maddalena Guandalini, Maddalena Bertolazzo, Stefano Ziccardi, Federica Virla, Valentina Camera, Damiano Marastoni, Agnese Tamanti et al. · 2024 · Journal of Neuroinflammation
  20. NKG2D ligand expression in pediatric brain tumors
    Kristen Haberthur, Kathryn Brennan, Virginia J. Hoglund, Stephanie D Balcaitis, Harrison K Chinn, Amira D Davis, Shannon A. Kreuser, Conrad Winter, Sarah E. S. Leary, Gail H. Deutsch et al. · 2016 · Cancer Biology & Therapy
  21. Korean Red Ginseng mitigates spinal demyelination in a model of acute multiple sclerosis by downregulating p38 mitogen-activated protein kinase and nuclear factor-κB signaling pathways
    Min Jung Lee, Byung Joon Chang, Seikwan Oh, Seung-Yeol Nah, Ik‐Hyun Cho · 2017 · Journal of Ginseng Research
  22. Concepts for Immunotherapies in Gliomas
    Michael Platten, David A. Reardon · 2018 · Seminars in Neurology
  23. Dimethyl fumarate therapy reduces memory T cells and the CNS migration potential in patients with multiple sclerosis
    Rikke Holm Hansen, Helene Højsgaard Chow, Jeppe Romme Christensen, Finn Thorup Sellebjerg, Marina Rode von Essen · 2019 · Multiple Sclerosis and Related Disorders
  24. Reelin depletion protects against autoimmune encephalomyelitis by decreasing vascular adhesion of leukocytes
    Laurent Calvier, Guillaume Demuth, Navid Manouchehri, Connie Hau Yan Wong, Anastasia Sacharidou, Chieko Mineo, Philip W. Shaul, Nancy L. Monson, Maria Z. Kounnas, Olaf Stüve et al. · 2020 · Science Translational Medicine
  25. Organic Selenium Reaches the Central Nervous System and Downmodulates Local Inflammation: A Complementary Therapy for Multiple Sclerosis?
    Juliana Helena dos Santos de Toledo, Thais Fernanda de Campos Fraga‐Silva, Patrícia Aparecida Borim, Larissa Ragozo Cardoso de Oliveira, Evelyn da Silva Oliveira, Larissa Lucena Périco, Clélia Akiko Hiruma-Lima, Adriana Aparecida Lopes de Souza, Carlos Alberto Ferreira de Oliveira, Pedro de Magalhães Padilha et al. · 2020 · Frontiers in Immunology
  26. The role of immune semaphorins in the pathogenesis of multiple sclerosis: Potential therapeutic targets
    Ramin Lotfi, Rasoul Nasiri Kalmarzi, Misagh Rajabinejad, Sabah Hasani, Fatemeh Zamani · 2021 · International Immunopharmacology
  27. Characterization of a natural variant of human NDP52 and its functional consequences on mitophagy
    Anthea Di Rita, Daniela Francesca Angelini, Teresa Maiorino, Valerio Caputo, Raffaella Cascella, Mukesh Kumar, Matteo Tiberti, Matteo Lambrughi, Nicole Wesch, Frank Löhr et al. · 2021 · Cell Death and Differentiation
  28. Recent advancements in nanoparticle-mediated approaches for restoration of multiple sclerosis
    Niloufar Rahiman, Marzieh Mohammadi, Seyedeh Hoda Alavizadeh, Leila Arabi, Ali Badiee, Mahmoud Reza Jaafari · 2022 · Journal of Controlled Release
  29. Neurodegeneration and convergent factors contributing to the deterioration of the cytoskeleton in Alzheimer's disease, cerebral ischemia and multiple sclerosis (Review)
    Johanna Andrea Gutiérrez Vargas, John Fredy Castro-Álvarez, José Fernando Zapata Berruecos, Komal Abdul‐Rahim, Anibal Arteaga‐Noriega · 2022 · Biomedical Reports
  30. Dual role of the nasal microbiota in neurological diseases—An unignorable risk factor or a potential therapy carrier
    Jin Xie, Shimin Tian, Jun Liu, Ruiyi Cao, Pengfei Yue, Xinfu Cai, Qiang Shang, Ming Hui Yang, Li Han, Dingkun Zhang · 2022 · Pharmacological Research
  31. Increased Intrathecal Activity of Follicular Helper T Cells in Patients With Relapsing-Remitting Multiple Sclerosis
    Rikke Holm Hansen, Jacob Talbot, Helene Højsgaard Chow, Malene Bredahl Hansen, Sophie Buhelt, Sebastian Herich, Nicholas Schwab, Marie N.N. Hellem, Jørgen Erik Nielsen, Finn Thorup Sellebjerg et al. · 2022 · Neurology Neuroimmunology & Neuroinflammation
  32. Synthesis and Comprehensive in Vivo Activity Profiling of Olean-12-en-28-ol, 3β-Pentacosanoate in Experimental Autoimmune Encephalomyelitis: A Natural Remyelinating and Anti-Inflammatory Agent
    Halil Şenol, Özden Özgün, Aydan Dağ, Ahmet Eken, Hüseyin Güner, Gamze Aykut, Gülaçtı Topçu, Alaattin Şen · 2023 · Journal of Natural Products
  33. Meningeal T cells function in the central nervous system homeostasis and neurodegenerative diseases
    Abdellatif Abbaoui, Oluwaseun Fatoba, Toshihide Yamashita · 2023 · Frontiers in Cellular Neuroscience
  34. ROS-Scavenging Lignin-Based Tolerogenic Nanoparticle Vaccine for Treatment of Multiple Sclerosis
    Ngoc Man Phan, Thanh Loc Nguyen, Hyunsu Shin, Thuy An Trinh, Jaeyun Kim · 2023 · ACS Nano
  35. A standardised frankincense extract reduces disease activity in relapsing-remitting multiple sclerosis (the SABA phase IIa trial)
    Klarissa Hanja Stürner, Jan‐Patrick Stellmann, Jan Dörr, Friedemann Paul, Tim Friede, Sven Schammler, Stefanie Reinhardt, Susanne Gellißen, Gainet Weissflog, Tobias Djamsched Faizy et al. · 2017 · Journal of Neurology Neurosurgery & Psychiatry
  36. Correlation Between Smoking and Passive Smoking with Multiple Sclerosis and the Underlying Molecular Mechanisms
    Zhaowei Wang, Jianpin Xie, Chenglong Wu, Gui-rong Xiao · 2019 · Medical Science Monitor
  37. Effect of Evobrutinib on Slowly Expanding Lesion Volume in Relapsing Multiple Sclerosis: A Post Hoc Analysis of a Phase 2 Trial
    Arnold, Douglas L., Elliott, Colm, Martin, Emily C., Hyvert, Yann, Tomic, Davorka, Montalban, Xavier · 2024 · Neurology
  38. Beyond the Magic Bullet: Current Progress of Therapeutic Vaccination in Multiple Sclerosis
    Barbara M. P. Willekens, Nathalie Cools · 2018 · CNS Drugs
  39. Communication of CD 8+ T cells with mononuclear phagocytes in multiple sclerosis
    Matea Konjevic Sabolek, Kathrin Held, Eduardo Beltrán, Anna G. Niedl, Edgar Meinl, Reinhard Hohlfeld, Hans Lassmann, Klaus Dornmair · 2019 · Annals of Clinical and Translational Neurology
  40. Plasma proteome in multiple sclerosis disease progression
    Arjan Malekzadeh, Cyra E Leurs, Wessel N. van Wieringen, Martijn D. Steenwijk, Menno Michiel Schoonheim, Michael Amann, Yvonne Naegelin, Jens Kühle, Joep Killestein, Charlotte Elisabeth Teunissen · 2019 · Annals of Clinical and Translational Neurology
  41. Pregnancy-Related Immune Changes and Demyelinating Diseases of the Central Nervous System
    Ke Qiu, Qiang He, Xiqian Chen, Hui Liu, Shuwen Deng, Wei Lu · 2019 · Frontiers in Neurology
  42. A critical analysis of helminth immunotherapy in multiple sclerosis
    Marc Charabati, Sarah J. Donkers, Megan C. Kirkland, Lisa C. Osborne · 2020 · Multiple Sclerosis Journal
  43. Impact of Vitamin D Supplementation on Multiple Sclerosis
    Fenil R Gandhi, Sharan Jhaveri, Chaithanya Avanthika, Abhishek Singh, Nidhi Jain, Azouba Gulraiz, Pratiksha Shah, Fareeha Nasir · 2021 · Cureus
  44. Immunoglobulin G N-glycan Biomarkers for Autoimmune Diseases: Current State and a Glycoinformatics Perspective
    Konstantinos Flevaris, Cleo Kontoravdi · 2022 · International Journal of Molecular Sciences
  45. The Translatability of Multiple Sclerosis Animal Models for Biomarkers Discovery and Their Clinical Use
    Dafni Birmpili, Imane Charmarke Askar, Kévin Bigaut, Dominique Bagnard · 2022 · International Journal of Molecular Sciences
  46. Probiotics and Commensal Gut Microbiota as the Effective Alternative Therapy for Multiple Sclerosis Patients Treatment
    Angela Dziedzic, Joanna Saluk · 2022 · International Journal of Molecular Sciences
  47. Impact of disease-modifying therapy on dendritic cells and exploring their immunotherapeutic potential in multiple sclerosis
    Caiyun Liu, Jie Zhu, Yan Mi, Tao Jin · 2022 · Journal of Neuroinflammation
  48. Gastrointestinal Tract, Microbiota and Multiple Sclerosis (MS) and the Link Between Gut Microbiota and CNS
    Bahman Yousefi, Ali Babaeizad, Seyedeh Zahra Banihashemian, Zahra Khatibiyan Feyzabadi, Mehdi Dadashpour, Daryoush Pahlevan, Hadi Ghaffari, Majid Eslami · 2022 · Current Microbiology
  49. Emodin attenuates inflammation and demyelination in experimental autoimmune encephalomyelitis
    Juan Feng, Yueran Cui, Zhongqi Bu, Haiyang Yu, Li-Li Yan · 2022 · Neural Regeneration Research
  50. Bone morphogenetic proteins in multiple sclerosis: Role in neuroinflammation
    Herena Eixarch, Laura Calvo‐Barreiro, Xavier Montalbán, Carmen Espejo · 2017 · Brain Behavior and Immunity
  51. Emerging Role for Methylation in Multiple Sclerosis: Beyond DNA
    Lindsay Webb, Mireia Guerau‐de‐Arellano · 2017 · Trends in Molecular Medicine
  52. Emerging role of semaphorin-3A in autoimmune diseases
    Lina Liu, Xiaomei Li, Dong‐Qing Ye, Hai‐Feng Pan · 2018 · Inflammopharmacology
  53. BP180 Autoantibodies Target Different Epitopes in Multiple Sclerosis or Alzheimer’s Disease than in Bullous Pemphigoid
    Jussi T. Tuusa, Outi Lindgren, Hanna-Mari Tertsunen, Wataru Nishie, Nina Kokkonen, Laura Huilaja, Kentaro Izumi, Sanna‐Kaisa Herukka, Jouko Miettunen, Hiroshi Shimizu et al. · 2018 · Journal of Investigative Dermatology
  54. Autologous Mesenchymal Stem Cell Transplantation in Multiple Sclerosis: A Meta-Analysis
    Yang Zhou, Xin Zhang, Hang Xue, Lingling Liu, Jie Zhu, Tao Jin · 2019 · Stem Cells International
  55. Crotoxin down-modulates pro-inflammatory cells and alleviates pain on the MOG35-55-induced experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis
    Nathália Bernardes Teixeira, Morena Brazil Sant’Anna, Aline C. Giardini, Leandro P. Araújo, L.A. Fonseca, Alexandre S. Basso, Yara Cury, Gisele Picolo · 2019 · Brain Behavior and Immunity
  56. The Pharmacogenetics of Rituximab: Potential Implications for Anti-CD20 Therapies in Multiple Sclerosis
    Michael Zhong, Anneke van der Walt, Maria Pia Campagna, Jim M. Stankovich, Helmut Butzkueven, Vilija Jokubaitis · 2020 · Neurotherapeutics
  57. The Effect of Peripheral Immune Cell Counts on the Risk of Multiple Sclerosis: A Mendelian Randomization Study
    Di He, Liyang Liu, Dongchao Shen, Peng Zou, Liying Cui · 2022 · Frontiers in Immunology
  58. Aryl hydrocarbon receptor activity downstream of IL-10 signaling is required to promote regulatory functions in human dendritic cells
    Daniele Avancini, Alessandro Testori, Lucia Fresolone, Grazia Andolfi, Michela Vuono, Vittorio Martinelli, Francesca R. Santoni de Sio, Silvia Gregori · 2023 · Cell Reports
  59. Decreased expression of Sema3A, an immune modulator, in blood sample of multiple sclerosis patients
    Mahsa Rezaeepoor, Shima Shapoori, Mazdak Ganjalıkhani-Hakemi, Masoud Etemadifar, Fereshteh Alsahebfosoul, Nahid Eskandari, Marjan Mansourian · 2017 · Gene
  60. Molecular and Metabolic Imaging in Multiple Sclerosis
    Marcello Moccia, Olga Ciccarelli · 2017 · Neuroimaging Clinics of North America
  61. Calming Down Mast Cells with Ketotifen: A Potential Strategy for Multiple Sclerosis Therapy?
    Karen Henriette Pinke, Sofia Fernanda Gonçalves Zorzella-Pezavento, Thais Fernanda de Campos Fraga‐Silva, Luiza Ayumi Nishiyama Mimura, Larissa Ragozo Cardoso de Oliveira, Larissa Lumi Watanabe Ishikawa, Ana Angélica Henrique Fernandes, Vanessa Soares Lara, Alexandrina Sartori · 2019 · Neurotherapeutics
  62. Potential Biomarker and Therapeutic LncRNAs in Multiple Sclerosis Through Targeting Memory B Cells
    Elahe Ghoveud, Shohreh Teimuri, Jafar Vatandoost, Aref Hosseini, Kamran Ghaedi, Masood Etemadifar, Mohammad Hossein Nasr‐Esfahani, Timothy L. Megraw · 2019 · NeuroMolecular Medicine
  63. Kombucha ameliorates experimental autoimmune encephalomyelitis through activation of Treg and Th2 cells
    Dariush Haghmorad, Esmaeil Yazdanpanah, Bizhan Sadighi‐Moghaddam, Bahman Yousefi, Pegah Sahafi, Narges Ghorbani, Ali Rashidy‐Pour, Parviz Kokhaei · 2020 · Acta Neurologica Belgica
  64. A comparative study of the effects of yoga and clinical Pilates training on walking, cognition, respiratory functions, and quality of life in persons with multiple sclerosis: A quasi-experimental study
    Zuhal Abasıyanık, Pınar Yiğit, Asiye Tuba Özdoğar, Turhan Kahraman, Özge Ertekin, Serkan Özakbaş · 2020 · EXPLORE
  65. Differential effects of estradiol and progesterone on human T cell activation in vitro
    Georgia Papapavlou, Sandra Hellberg, Johanna Raffetseder, Jan Brynhildsen, Mika Gustafsson, Maria Christina Jenmalm, Jan Ernerudh · 2021 · European Journal of Immunology
  66. Detection of Neurofilament Light Chain with Label‐Free Electrolyte‐Gated Organic Field‐Effect Transistors
    Kateryna Solodka, Marcello Berto, Diana Ferraro, Claudia Menozzi, Marco Borsari, Carlo Augusto Bortolotti, Fabio Biscarini, Marcello Pinti · 2022 · Advanced Materials Interfaces
  67. Remyelination in multiple sclerosis from the miRNA perspective
    Maciak, Karina, Dziedzic, Angela, Saluk, Joanna · 2023 · Frontiers in Molecular Neuroscience
  68. Is Geo-Environmental Exposure a Risk Factor for Multiple Sclerosis? A Population-Based Cross-Sectional Study in South-Western Sardinia
    Maria Cristina Monti, Davide Guido, Cristina Montomoli, Claudia Sardu, Alessandro Sanna, Salvatore Pretti, Lorena Lorefice, Maria Giovanna Marrosu, Paolo Valera, Eleonora E. Cocco · 2016 · PLoS ONE
  69. The autoimmune risk gene ZMIZ1 is a vitamin D responsive marker of a molecular phenotype of multiple sclerosis
    Nicole Fewings, Prudence N. Gatt, Fiona C. McKay, Grant Peter Parnell, Stephen D. Schibeci, Jarem J. Edwards, Monica A. Basuki, Anita Goldinger, Marzena J. Fabis‐Pedrini, Allan G. Kermode et al. · 2017 · Journal of Autoimmunity
  70. Ocrelizumab for the treatment of multiple sclerosis
    Kévin Bigaut, Jerome De Seze, Nicolas Collongues · 2018 · Expert Review of Neurotherapeutics
  71. Novel insights into the mechanisms underlying depression-associated experimental autoimmune encephalomyelitis
    Eduardo Pereira Duarte-Silva, Danielle S. Macêdo, Michael H. J. Maes, Christina Alves Peixoto · 2019 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  72. Short-term sleep deprivation in mice induces B cell migration to the brain compartment
    Ben Korin, Shimrit Avraham, Hilla Azulay‐Debby, Dorit Farfara, Fahed Hakim, Asya Rolls · 2019 · SLEEP
  73. LRR domain of NLRX1 protein delivery by dNP2 inhibits T cell functions and alleviates autoimmune encephalomyelitis
    Ja‐Hyun Koo, Do-Hyun Kim, Donghun Cha, Min‐Jong Kang, Je‐Min Choi · 2020 · Theranostics
  74. Impact of Exercise on Immunometabolism in Multiple Sclerosis
    Remsha Afzal, Jennifer K. Dowling, Claire E. McCoy · 2020 · Journal of Clinical Medicine
  75. Human gut microbiota and its association with pathogenesis and treatments of neurodegenerative diseases
    Zhong Chen, Javeria Maqbool, Faiqa Sajid, Ghulam Hussain, Tao Sun · 2020 · Microbial Pathogenesis
  76. Cerebral microvascular endothelial cell-derived extracellular vesicles regulate blood − brain barrier function
    Baharak Hosseinkhani, Gayel Duran, Cindy Hoeks, Doryssa Hermans, Melissa Schepers, Paulien Baeten, Joren Poelmans, Britt A. Coenen, Kübra Bekar, Isabel Pintelon et al. · 2023 · Fluids and Barriers of the CNS
  77. NURR1 Impairment in Multiple Sclerosis
    Francesca Montarolo, Serena Martire, Simona Perga, Antonio Bertolotto · 2019 · International Journal of Molecular Sciences
  78. Association between diurnal temperature range and emergency department visits for multiple sclerosis: A time-stratified case-crossover study
    Seonjeong Byun, Woojae Myung, Ho Kim, Hyewon Lee · 2020 · The Science of The Total Environment
  79. Dysregulation of metabolic pathways by carnitine palmitoyl-transferase 1 plays a key role in central nervous system disorders: experimental evidence based on animal models
    Michael Sloth Trabjerg, Anne Skøttrup Mørkholt, Jacek Lichota, Michal Krystian Oklinski, Dennis Christian Andersen, Katrine Jønsson, Kasper Mørk, Marie-Louise Nibelius Skjønnemand, Lona John Kroese, Colin E.J. Pritchard et al. · 2020 · Scientific Reports
  80. Neuroinflammation in Autoimmune Disease and Primary Brain Tumors: The Quest for Striking the Right Balance
    Dana K. Mitchell, Jack M. Shireman, Elizabeth A. Sierra Potchanant, Montserrat A. Lara-Velazquez, Mahua Dey · 2021 · Frontiers in Cellular Neuroscience
  81. Adipokines as Immune Cell Modulators in Multiple Sclerosis
    Merel Rijnsburger, Niek Djuric, Inge A. Mulder, Helga E. de Vries · 2021 · International Journal of Molecular Sciences
  82. Obesity and the Brain
    Jacek Karczewski, Aleksandra Zielińska, R. Staszewski, Piotr Eder, Agnieszka Dobrowolska, Eliana B. Souto · 2022 · International Journal of Molecular Sciences
  83. Ginsenoside Rg1 promotes remyelination and functional recovery in demyelinating disease by enhancing oligodendrocyte precursor cells-mediated myelin repair
    Li Liu, Xinke Du, Qing Kun Yang, Manjing Li, Qingsen Ran, Qingwu Liu, Lina Yang, Lisong Sun, Yuxuan Guo, Yujie Li et al. · 2022 · Phytomedicine
  84. How Microbiota-Derived Metabolites Link the Gut to the Brain during Neuroinflammation
    Jessica Rebeaud, Benjamin Peter, Caroline Pot · 2022 · International Journal of Molecular Sciences
  85. IRAK-M Suppresses the Activation of Microglial NLRP3 Inflammasome and GSDMD-Mediated Pyroptosis Through Inhibiting IRAK1 Phosphorylation During Experimental Autoimmune Encephalomyelitis
    Yuanyuan Wang, Shanshan Pei, Zhuhe Liu, Yuewen Ding, Tinglin Qian, Haixia Wen, Ssu‐Wei Hsu, Zheyi Zhou, Jun Zhang, Honghao Wang · 2022 · Cell Death and Disease
  86. Innovative drug delivery strategies to the CNS for the treatment of multiple sclerosis
    Ariane Mwema, Giulio G. Muccioli, Anne des Rieux · 2023 · Journal of Controlled Release
  87. The influence of gut-derived CD39 regulatory T cells in CNS demyelinating disease
    Javier Ochoa‐Repáraz, Lloyd H. Kasper · 2016 · Translational research
  88. Toll-like receptor-mediated immune responses in intestinal macrophages; implications for mucosal immunity and autoimmune diseases
    Zejun Zhou, Miao Ding, Lei Huang, Gary S. Gilkeson, Ren Lang, Wei Jiang · 2016 · Clinical Immunology
  89. Roles of regulatory T cells and IL-10 in virus-induced demyelination
    Stanley M. Perlman, Jingxian Zhao · 2017 · Journal of Neuroimmunology
  90. Reduced rich-club connectivity is related to disability in primary progressive MS
    Jan‐Patrick Stellmann, Sibylle C. Hodecker, Bastian Cheng, Nadine Wanke, Kim Lea Young, Claus Christian Hilgetag, Christian P Gerloff, Christoph Heesen, Götz Thomalla, Susanne Gellißen · 2017 · Neurology Neuroimmunology & Neuroinflammation
  91. Voltage Gated Potassium Channel Kv1.3 Is Upregulated on Activated Astrocytes in Experimental Autoimmune Encephalomyelitis
    Iva D. Bozic, Katarina Tesovic, Danijela Laketa, Marija Adžić, Marija Jakovljevic, Ivana M. Bjelobaba, Danijela Z. Savić, Nadežda Nedeljković, Sanja Peković, Irena C. Lavrnja · 2018 · Neurochemical Research
  92. Dimethyl fumarate therapy suppresses B cell responses and follicular helper T cells in relapsing-remitting multiple sclerosis
    Rikke Holm Hansen, Helene Højsgaard Chow, Finn Thorup Sellebjerg, Marina Rode von Essen · 2018 · Multiple Sclerosis Journal
  93. TRPA1 activation mediates nociception behaviors in a mouse model of relapsing-remitting experimental autoimmune encephalomyelitis
    Diéssica Padilha Dalenogare, Maria Carolina Theisen, Diulle Spat Peres, Maria Fernanda Pessano Fialho, Débora Denardin Lückemeyer, Caren Tatiane de David Antoniazzi, Sabrina Qader Kudsi, Marcella de Amorim Ferreira, Camila dos Santos Ritter, Juliano Ferreira et al. · 2020 · Experimental Neurology
  94. Cladribine modifies functional properties of microglia
    Line Jorgensen, Kirsten H. Hyrlov, Maria L. Elkjaer, A B Weber, Anders Elm Pedersen, Åsa Fex Svenningsen, Zsolt Illés · 2020 · Clinical & Experimental Immunology
  95. The influence of MOGAD on diagnosis of multiple sclerosis using MRI
    Ruth Geraldes, Georgina Arrambide, Brenda Banwell, Àlex Rovira, Rosa Cortese, Hans Lassmann, Silvia Messina, Maria Assunta Rocca, Patrick Joseph Waters, Declan Chard et al. · 2024 · Nature Reviews Neurology
  96. Immunomodulatory effects and clinical application of exosomes derived from mesenchymal stem cells
    Yangfei Yi, Zi-Qi Fan, Can Liu, Yi-Tong Ding, Yao Chen, Jie Wen, Xiao-Hong Jian, Yu-Fei Li · 2025 · World Journal of Stem Cells
  97. Microglia regulate myelin clearance and cholesterol metabolism after demyelination via interferon regulatory factor 5
    Alejandro Montilla, Alazne Zabala, Ibai Calvo, Marina Bosch-Juan, Irene Tomé Velasco, Paloma Mata, Mirjam Koster, Amanda Sierra, Susanne M. Kooistra, Federico Nicolás Soria et al. · 2025 · Cellular and Molecular Life Sciences
  98. NLRP3 activation induces BBB disruption and neutrophil infiltration via CXCR2 signaling in the mouse brain
    Jaeho Lee, Wooyoung Cho, Je‐Wook Yu, Young‐Min Hyun · 2025 · Journal of Neuroinflammation
  99. Hormesis and Defense of Infectious Disease
    Sebastian Weis, Ignacio Rubio, Kristin Ludwig, Cynthia Weigel, Elisa Jentho · 2017 · International Journal of Molecular Sciences
  100. The epigenetic drug Trichostatin A ameliorates experimental autoimmune encephalomyelitis via T cell tolerance induction and impaired influx of T cells into the spinal cord
    Arathi K. Jayaraman, Advait Soni, Bellur S. Prabhakar, Mark Holterman, Sundararajan Jayaraman · 2017 · Neurobiology of Disease